dr. nanda on pembrolizumab potential for tnbc
Published 9 years ago • 390 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
0:56
dr. nanda on immunotherapy in metastatic tnbc
-
6:10
pd-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
-
1:36
dr. hurvitz on pembrolizumab for tnbc
-
5:49
immunotherapy for tnbc
-
8:32
immunotherapy for triple-negative breast cancer
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
1:56
dr. schmid on benefit of pembrolizumab in patients with tnbc
-
2:50
results for pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer
-
2:07
tnbc: using checkpoint inhibitors alone or with chemotherapy
-
6:01
immunotherapy for triple-negative breast cancer
-
3:45
immunotherapy for tnbc
-
0:58
dr. carey on de-escalating treatments for triple-negative breast cancer
-
2:11
dr. muro on pembrolizumab for gastric cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
1:00
dr. papadimitrakopoulou provides an update on pembrolizumab for lung cancer
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
21:00
precision medicine in metastatic triple negative breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc